Literature DB >> 29725952

Drug plasma level measurement in management of severe bleeding during direct oral anticoagulant treatment: case report and perspective.

Dimitriy Arioli1, Davide Donelli2,3, Lorenzo Morini4, Maria Cristina Leone1, Emanuele Alberto Negri4.   

Abstract

Entities:  

Keywords:  Direct oral anticoagulants; Drug plasma levels; Haemostasis; Management; Severe bleeding; Thrombosis

Mesh：

Substances：

Year:  2018        PMID： 29725952     DOI： 10.1007/s11739-018-1858-2

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN： 1828-0447            Impact factor:   3.397


× No keyword cloud information.
  6 in total

1.  Italian intersociety consensus on DOAC use in internal medicine.

Authors:  Domenico Prisco; Walter Ageno; Cecilia Becattini; Armando D'Angelo; Giovanni Davì; Raimondo De Cristofaro; Francesco Dentali; Giovanni Di Minno; Anna Falanga; Gualberto Gussoni; Luca Masotti; Gualtiero Palareti; Pasquale Pignatelli; Roberto M Santi; Francesca Santilli; Mauro Silingardi; Antonella Tufano; Francesco Violi
Journal:  Intern Emerg Med       Date:  2017-02-13       Impact factor: 3.397

Review 2.  2017 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways.

Authors:  Gordon F Tomaselli; Kenneth W Mahaffey; Adam Cuker; Paul P Dobesh; John U Doherty; John W Eikelboom; Roberta Florido; William Hucker; Roxana Mehran; Steven R Messé; Charles V Pollack; Fatima Rodriguez; Ravindra Sarode; Deborah Siegal; Barbara S Wiggins
Journal:  J Am Coll Cardiol       Date:  2017-12-01       Impact factor: 24.094

3.  Position Paper on laboratory testing for patients on direct oral anticoagulants. A Consensus Document from the SISET, FCSA, SIBioC and SIPMeL.

Authors:  Armando Tripodi; Walter Ageno; Marcello Ciaccio; Cristina Legnani; Giuseppe Lippi; Cesare Manotti; Rossella Marcucci; Marco Moia; Benedetto Morelli; Daniela Poli; Agostino Steffan; Sophie Testa
Journal:  Blood Transfus       Date:  2017-09-13       Impact factor: 3.443

Review 4.  Periprocedural management of patients receiving a vitamin K antagonist or a direct oral anticoagulant requiring an elective procedure or surgery.

Authors:  A C Spyropoulos; A Al-Badri; M W Sherwood; J D Douketis
Journal:  J Thromb Haemost       Date:  2016-04-07       Impact factor: 5.824

5.  Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation.

Authors:  Hein Heidbuchel; Peter Verhamme; Marco Alings; Matthias Antz; Hans-Christoph Diener; Werner Hacke; Jonas Oldgren; Peter Sinnaeve; A John Camm; Paulus Kirchhof
Journal:  Europace       Date:  2015-08-31       Impact factor: 5.214

Review 6.  When and how to use antidotes for the reversal of direct oral anticoagulants: guidance from the SSC of the ISTH.

Authors:  J H Levy; W Ageno; N C Chan; M Crowther; P Verhamme; J I Weitz
Journal:  J Thromb Haemost       Date:  2016-02-17       Impact factor: 5.824
  6 in total
  2 in total

1.  A focus on direct oral anticoagulants: "old" and possible new indications and efforts for a better clinical management.

Authors:  Domenico Prisco
Journal:  Intern Emerg Med       Date:  2018-09-21       Impact factor: 3.397

Review 2.  Direct Oral Anticoagulants in Patients with Liver Disease in the Era of Non-Alcoholic Fatty Liver Disease Global Epidemic: A Narrative Review.

Authors:  Stefano Ballestri; Mariano Capitelli; Maria Cristina Fontana; Dimitriy Arioli; Elisa Romagnoli; Catia Graziosi; Amedeo Lonardo; Marco Marietta; Francesco Dentali; Giorgio Cioni
Journal:  Adv Ther       Date:  2020-04-13       Impact factor: 3.845
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.